| |
| |
|
| Insider
Information: |
Fernandes Peter |
| Relationship: |
|
| City: |
Hampton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
22,515 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,275 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
22,515 |
|
|
| Total
Value |
$6,275 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bellerophon Therapeutics Inc |
BLPH |
|
2022-12-09 |
22,515 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BLPH |
Bellerophon Therapeutics ... |
PRINCIPAL EXECUTIVE OFFICER |
• – – |
2022-12-09 |
4 |
D |
$0.93 |
$9,287 |
D/D |
(9,985) |
22,515 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
PRINCIPAL EXECUTIVE OFFICER |
• – – |
2022-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,500 |
32,500 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Chief Regulatory & Safety Offr |
• – – |
2019-11-15 |
4 |
D |
$0.34 |
$13,695 |
D/D |
(40,280) |
182,022 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Chief Regulatory & Safety Offr |
• – – |
2018-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
119,626 |
222,302 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Chief Regulatory & Safety Offr |
• – – |
2018-06-12 |
4 |
D |
$2.37 |
$26,790 |
D/D |
(11,304) |
102,676 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Chief Regulatory & Safety Offr |
• – – |
2018-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
31,527 |
113,980 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Chief Regulatory & Safety Offr |
• – – |
2018-01-04 |
4 |
D |
$2.49 |
$87,949 |
D/D |
(35,321) |
82,453 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Chief Regulatory & Safety Offr |
• – – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
82,052 |
117,774 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Chief Regulatory Officer |
• – – |
2016-09-12 |
4 |
D |
$1.38 |
$27,303 |
D/D |
(19,785) |
35,722 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Chief Regulatory Officer |
• – – |
2016-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
53,112 |
55,507 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Chief Regulatory OfficerOffice |
• – – |
2015-05-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,395 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
